Ozkan A, Apak H, Celkan T, Yüksel L, Yildiz I
Cerrahpasa Medical Faculty, Department of Pediatric Hematology-Oncology, University of Istanbul, Istanbul, Turkey.
Pediatr Dermatol. 2001 Jan-Feb;18(1):38-40. doi: 10.1046/j.1525-1470.2001.018001038.x.
We report a fatal case of toxic epidermal necrolysis (TEN) resulting from a high dose of cytosine arabinoside (ARA-C). A 13-year-old girl with acute lymphocytic leukemia was treated according to the protocol of the BFM Group (BFM-95, HRG). On the fifth day after administration of a high dose of ARA-C (2 g/m2 intravenously every 12 hours), she developed bullous lesions on the hands and soles that disseminated, evolving to necrosis, sepsis, and death on the 22nd day. ARA-C is frequently associated with dermatologic toxicity, but this is only the second case of toxic epidermal necrolysis described in connection with this drug.
我们报告了一例因高剂量阿糖胞苷(ARA-C)导致的中毒性表皮坏死松解症(TEN)致死病例。一名13岁急性淋巴细胞白血病女孩按照BFM组(BFM-95,HRG)方案进行治疗。在静脉注射高剂量阿糖胞苷(每12小时2 g/m²)后的第5天,她的手部和脚底出现水疱性病变,病变扩散,在第22天发展为坏死、败血症并死亡。阿糖胞苷常与皮肤毒性相关,但这是第二例与该药物相关的中毒性表皮坏死松解症病例。